Literature DB >> 21292165

The structural basis for tight control of PP2A methylation and function by LCMT-1.

Vitali Stanevich1, Li Jiang, Kenneth A Satyshur, Yongfeng Li, Philip D Jeffrey, Zhu Li, Patrick Menden, Martin F Semmelhack, Yongna Xing.   

Abstract

Proper formation of protein phosphatase 2A (PP2A) holoenzymes is essential for the fitness of all eukaryotic cells. Carboxyl methylation of the PP2A catalytic subunit plays a critical role in regulating holoenzyme assembly; methylation is catalyzed by PP2A-specific methyltransferase LCMT-1, an enzyme required for cell survival. We determined crystal structures of human LCMT-1 in isolation and in complex with PP2A stabilized by a cofactor mimic. The structures show that the LCMT-1 active-site pocket recognizes the carboxyl terminus of PP2A, and, interestingly, the PP2A active site makes extensive contacts to LCMT-1. We demonstrated that activation of the PP2A active site stimulates methylation, suggesting a mechanism for efficient conversion of activated PP2A into substrate-specific holoenzymes, thus minimizing unregulated phosphatase activity or formation of inactive holoenzymes. A dominant-negative LCMT-1 mutant attenuates the cell cycle without causing cell death, likely by inhibiting uncontrolled phosphatase activity. Our studies suggested mechanisms of LCMT-1 in tight control of PP2A function, important for the cell cycle and cell survival.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292165      PMCID: PMC3060061          DOI: 10.1016/j.molcel.2010.12.030

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  45 in total

Review 1.  Protein phosphatase 2A: a panoply of enzymes.

Authors:  D M Virshup
Journal:  Curr Opin Cell Biol       Date:  2000-04       Impact factor: 8.382

2.  A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo.

Authors:  Thomas Fellner; Daniel H Lackner; Hans Hombauer; Patrick Piribauer; Ingrid Mudrak; Katrin Zaragoza; Claudia Juno; Egon Ogris
Journal:  Genes Dev       Date:  2003-09-01       Impact factor: 11.361

Review 3.  PP2A: the expected tumor suppressor.

Authors:  Veerle Janssens; Jozef Goris; Christine Van Hoof
Journal:  Curr Opin Genet Dev       Date:  2005-02       Impact factor: 5.578

4.  Protein phosphatase 2A catalytic subunit is methyl-esterified at its carboxyl terminus by a novel methyltransferase.

Authors:  J Lee; J Stock
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

5.  Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis.

Authors:  Estelle Sontag; Christa Hladik; Lisa Montgomery; Ampa Luangpirom; Ingrid Mudrak; Egon Ogris; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2004-10       Impact factor: 3.685

6.  The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis.

Authors:  Mei Kong; Casey J Fox; James Mu; Laura Solt; Anne Xu; Ryan M Cinalli; Morris J Birnbaum; Tullia Lindsten; Craig B Thompson
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

Review 7.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 8.  Serine/threonine phosphatases: mechanism through structure.

Authors:  Yigong Shi
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

9.  Okadaic acid and microcystin-LR directly inhibit the methylation of protein phosphatase 2A by its specific methyltransferase.

Authors:  M Li; Z Damuni
Journal:  Biochem Biophys Res Commun       Date:  1994-07-29       Impact factor: 3.575

10.  Alpha4 is an essential regulator of PP2A phosphatase activity.

Authors:  Mei Kong; Dara Ditsworth; Tullia Lindsten; Craig B Thompson
Journal:  Mol Cell       Date:  2009-10-09       Impact factor: 17.970

View more
  52 in total

1.  Global loss of leucine carboxyl methyltransferase-1 causes severe defects in fetal liver hematopoiesis.

Authors:  Jocelyn A Lee; Zhengqi Wang; Danielle Sambo; Kevin D Bunting; David C Pallas
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

2.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 3.  PP2A as a master regulator of the cell cycle.

Authors:  Nathan Wlodarchak; Yongna Xing
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-02-24       Impact factor: 8.250

4.  A Metabolic Function for Phospholipid and Histone Methylation.

Authors:  Cunqi Ye; Benjamin M Sutter; Yun Wang; Zheng Kuang; Benjamin P Tu
Journal:  Mol Cell       Date:  2017-03-30       Impact factor: 17.970

5.  Demethylation of the Protein Phosphatase PP2A Promotes Demethylation of Histones to Enable Their Function as a Methyl Group Sink.

Authors:  Cunqi Ye; Benjamin M Sutter; Yun Wang; Zheng Kuang; Xiaozheng Zhao; Yonghao Yu; Benjamin P Tu
Journal:  Mol Cell       Date:  2019-02-13       Impact factor: 17.970

6.  Human C6orf211 encodes Armt1, a protein carboxyl methyltransferase that targets PCNA and is linked to the DNA damage response.

Authors:  J Jefferson P Perry; Gregory D Ballard; Alexandra E Albert; Lacey E Dobrolecki; Linda H Malkas; Derek J Hoelz
Journal:  Cell Rep       Date:  2015-02-26       Impact factor: 9.423

7.  Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.

Authors:  Xiaobing Dou; Yongliang Xia; Jing Chen; Ying Qian; Songtao Li; Ximei Zhang; Zhenyuan Song
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

8.  PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments.

Authors:  Russell E Nicholls; Jean-Marie Sontag; Hong Zhang; Agnieszka Staniszewski; Shijun Yan; Carla Y Kim; Michael Yim; Caitlin M Woodruff; Erland Arning; Brandi Wasek; Deqi Yin; Teodoro Bottiglieri; Estelle Sontag; Eric R Kandel; Ottavio Arancio
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

Review 9.  Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.

Authors:  Godfrey Grech; Shawn Baldacchino; Christian Saliba; Maria Pia Grixti; Robert Gauci; Vanessa Petroni; Anthony G Fenech; Christian Scerri
Journal:  Tumour Biol       Date:  2016-07-21

10.  Phosphoinositide 3-kinase γ inhibits cardiac GSK-3 independently of Akt.

Authors:  Maradumane L Mohan; Babal K Jha; Manveen K Gupta; Neelakantan T Vasudevan; Elizabeth E Martelli; John David Mosinski; Sathyamangla V Naga Prasad
Journal:  Sci Signal       Date:  2013-01-22       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.